Tomas Kalincik

Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study.

Mathias Due Buron, Tomas Kalincik, Finn Sellebjerg, Per Soelberg Sørensen, Melinda Magyari

Journal article  |  2021  |  Journal of Neurology Neurosurgery & Psychiatry

BACKGROUND: Switching between first-line disease-modifying therapies in patients with clinically stable relapsing-remitting multip..

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis.

Tomas Uher, Jan Krasensky, Charles Malpas, Niels Bergsland, Michael G Dwyer, Eva Kubala Havrdova, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, Tomas Kalincik

Journal article  |  2021  |  Neurology Neuroimmunology & Neuroinflammation

OBJECTIVE: To describe the dynamics of brain volume loss (BVL) at different stages of relapsing-remitting multiple sclerosis (RRMS..

Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.

James Broadley, Robb Wesselingh, Udaya Seneviratne, Chris Kyndt, Paul Beech, Katherine Buzzard, Cassie Nesbitt, Wendyl D'souza, Amy Brodtmann, Richard Macdonell, Tomas Kalincik, Helmut Butzkueven, Terence J O'Brien, Mastura Monif, undefined Australian Autoimmune Encephalitis Consortium

Journal article  |  2021  |  Journal of Neuroimmunology

OBJECTIVE: To examine the prognostic value of CSF abnormalities in seropositive autoimmune encephalitis (AE). METHODS: We retrospe..

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.

Tomas Kalincik, Ibrahima Diouf, Sifat Sharmin, Charles Malpas, Tim Spelman, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Vahid Shaygannejad, et al.

Journal article  |  2021  |  Neurology

OBJECTIVE: To test the hypothesis that immunotherapy prevents long-term disability in relapsing-remitting multiple sclerosis (MS),..

Adverse events related to antiepileptic drugs

Yew Li Dang, Emma Foster, Michael Lloyd, Genevieve Rayner, Maria Rychkova, Rashida Ali, Patrick W Carney, Dennis Velakoulis, Toby T Winton-Brown, Tomas Kalincik, Piero Perucca, Terence J O'Brien, Patrick Kwan, Charles B Malpas

Journal article  |  2021  |  Epilepsy & Behavior

OBJECTIVE: Adverse events (AEs) related to antiepileptic drugs (AEDs) may interfere with adequate dosing and patient adherence, le..

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

James Broadley, Robb Wesselingh, Udaya Seneviratne, Chris Kyndt, Paul Beech, Katherine Buzzard, Cassie Nesbitt, Wendyl D'Souza, Amy Brodtmann, Tomas Kalincik, Helmut Butzkueven, Terence J O'Brien, Mastura Monif

Journal article  |  2021  |  Frontiers in Immunology

Objective: To examine the utility of the peripheral blood neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (M..

Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.

Francesca Bovis, Tomas Kalincik, Fred Lublin, Gary Cutter, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Murat Terzi, Pierre Grammond, Roberto Bergamaschi, Patrizia Sola, et al.

Journal article  |  2021  |  Neurology

OBJECTIVE: To compare the effectiveness of glatiramer acetate (GA) vs intramuscular interferon beta-1a (IFN-β-1a), we applied a pr..

Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?

Tomas Kalincik, Maria Pia Sormani, Carmen Tur

Journal article  |  2021  |  Neurology

The prevalence of epileptic seizures in multiple sclerosis in a large tertiary hospital in Australia.

Suyi Ooi, Tomas Kalincik, Piero Perucca, Mastura Monif

Journal article  |  2021  |  Multiple Sclerosis Journal - Experimental Translational and Clinical

Rationale: To determine the prevalence of epileptic seizures in multiple sclerosis (MS) at an Australian tertiary hospital and to ..

Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic

Louise Rath, Minh Viet Bui, Julian Ellis, John Carey, Josephine Baker, Lisa Taylor, Hasini Fernando, Nicola Taylor, Poppy Savage, Janene Richards, Michael Zhong, Tomas Kalincik, Olga Skibina, Robb Wesselingh, Ai-Lan Nguyen, Mastura Monif, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2021  |  Multiple Sclerosis and Related Disorders

BACKGROUND: The COVID-19 pandemic challenges multiple sclerosis services to be innovative in delivering infusible therapies. To re..